Walleye Capital’s Aceragen Inc ACGN Stock Holding History

Walleye Capital’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-943	Closed	-$41K	–	2158
2019 Q1	$41K	Buy	+943	New	+$45.6K	0.01%	1253

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's ACGN Position: Q2 2019 in Review

Walleye Capital sold out of Aceragen Inc (ACGN) in Q2 2019, closing a stake of 943 shares — an estimated $41K sold.

Walleye Capital first reported a position in ACGN in Q1 2019 and held it in 1 quarter. The position peaked at $41K in Q1 2019. 56 funds tracked by Wall St. Rank hold ACGN as of Q2 2019.

Walleye Capital reported no remaining Aceragen Inc position as of Q2 2019 after selling out during the quarter.
Walleye Capital sold 943 Aceragen Inc shares in Q2 2019, an estimated $41K.
Walleye Capital first reported a position in Aceragen Inc in Q1 2019 and held it in 1 quarter.
Walleye Capital's Aceragen Inc position peaked at $41K in Q1 2019.
56 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2019.

Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.